Last change: June 12, 2003

Number of records: 18

This list of publications is in alphabetical order concerning the names of the first author.

Bauer, R.; Brust, P.; Walter, B.; Vorwieger, G.; Bergmann, R.; Elhalag, E.; Fritz, A.; Steinbach, J.; Füchtner, F.; Hinz, R.; Zwiener, U.; Johannsen, B.
Effect of hypoxia/hypercapnia on metabolism of 6-[18F]fluoro-L-DOPA in newborn piglets
Brain Res., 934, 2002, 23-33

Bergmann, R.; Scheunemann, M.; Heichert, C.; Mäding, P.; Wittrisch, H.; Kretzschmar, M.; Rodig, H.; Tourwé, D.; Iterbeke, K.; Chavatte, K.; Zips, D.; Reubi, J. C.; Johannsen, B.
Biodistribution and catabolism of 18F-labeled neurotensin(8-13) analogs
Nucl. Med. Biol., 29, 2002, 61-72

Brust, P.; Rodig, H.; Römer, J.; Kasch, H.; Bergmann, R.; Füchtner, F.; Zips, D.; Baumann, M.; Steinbach, J.; Johannsen, B.
Distribution of 16alpha[18F]fluoro-estradiol-3,17beta-disulfamate (FESDS) in rats, tumour-bearing mice and piglets
Appl. Radiat. Isot., 57, 2002, 687-695

Drews, A.; Pietzsch, H.-J.; Syhre, R.; Seifert, S.; Varnäs, K.; Hall, H.; Halldin, C.; Kraus, W.; Karlsson, P.; Johnsson, C.; Spies, H.; Johannsen, B.
Synthesis and biological evaluation of technetium(III) mixed-ligand complexes with high affinity for the cerebral 5-HT1A receptor and the alpha1-adrenergic receptor
Nucl. Med. Biol., 29, 2002, 389-398

Füchtner, F.; Angelberger, P.; Kvaternik, H.; Hammerschmidt, F.; Peric Simovc, B.; Steinbach, J.
Aspects of 6-[18F]fluoro-L-DOPA preparation: Precursor synthesis, preparative HPLC purification and determination of radiochemical purity
Nucl. Med. Biol., 29, 2002, 477-481

Gloe, K.; Stephan, H.; Grotjahn, M.
Quo vadis Anionenextraktion?
Chem.Ing.Tech., 74, 2002, 767-777

Heimbold, I.; Drews, A.; Kretzschmar, M.; Varnäs, K.; Hall, H.; Halldin, C.; Syhre, R.; Kraus, W.; Pietzsch, H.-J.; Seifert, S.; Brust, P.; Johannsen, B.
Synthesis , biological and autoradiographic evaluation of a novel Tc-99m radioligand derived from WAY 100635 with high-affinity for the 5-HT1A receptor and the alpha1-adrenergic receptor
Nucl. Med. Biol., 29, 2002, 375-387

Heimbold, I.; Drews, A.; Syhre, R.; Kretzschmar, M.; Pietzsch, H.-J.; Johannsen, B.
A novel technetium-99m radioligand for the 5-HT1A receptor derived from desmethyl-WAY-100635 (DWAY)
Eur. J. Nucl. Med., 29, 2002, 82-87

Henkel, E.; Temelkova-Kurtschiev, T.; Köhler, C.; Pietzsch, J.; Leonhardt, W.; Hanefeld, M
Impaired glucose tolerance is not associated with lipid intolerance
Diab. Nutr. Metab., 15, 2002, 84-90

Johannsen, B.; Pietzsch, H.-J.
Development of technetium-99m-based CNS receptor ligands: have there been any advances?
Eur. J. Nucl. Med., 29, 2002, 263-275

Jung, Christian M.; Kraus, W.; Leibnitz, P.; Pietzsch, H.-J.; Kropp, J.; Spies, H.
Syntheses and first crystal structures of rhenium complexes derived from omega-functionalized fatty acids as model compounds of technetium tracers for myocardial metabolism imaging
Eur. J. Inorg. Chem., 2002, 1219-1225

Knieß, T.; Spies, H.; Santos, I.; Zablotskaya, A.
Synthesis of hydroxyl silylated rhenium and (99mTc)technetium ‚3+1'mixed ligand complexes
Journal of Labelled Compounds and Radiopharmaceuticals, 45, 2002, 629-636

Kopprasch, S.; Pietzsch, J.; Kuhlisch, E.; Fuecker, K.; Temelkova-Kurktschiev, T.; Hanefeld, M.; Kühne, H.; Julius, U.; Graessler, J.
In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance
Diabetes, 51, 2002, 3102-3106

Richter, T.; Steiner, G.; Abu-Id, Mario H.; Salzer, R.; Bergmann, R.; Rodig, H.; Johannsen, B.
Identification of tumor tissue by FTIR spectroscopy in combination with positron emission tomography
Vib. Spectr., 28, 2002, 103-110

Rodig, H.; Brust, P.; Römer, J.; Kasch, H.; Bergmann, R.; Füchtner, F.; Steinbach, J.; Johannsen, B.
Distribution of estrone sulfatase in rat brain determined by in vitro autoradiography with 16alpha-[18F]fluoroestradiol-3,17beta-disulfamate
Appl. Radiat. Isot., 56, 2002, 773-780

Spies, H.; Noll, B.; Noll, S.; Findeisen, M.; Brust, P.; Syhre, R.; Berger, R.
Tc and Re chelates of 8alpha-amino-6-methyl-ergoline: synthesis and affinity to the dopamine D2 receptor
Bioorg. Med. Chem., 10, 2002, 3523-3528

Zablotskaya, A.; Segal, I.; Germane, S.; Shestakova, I.; Lukevics, E.; Knieß, T.; Spies, H.
Synthesis and biological activity of ‚3+1' mixed ligand (3-thiapentane-1,5-dithiolato)oxorhenium(V) complexes bearing 1,2,3,4-tetrahydro(iso)quinoline and quinoline
Appl. Organometal. Chem., 16, 2002, 550-555

Zablotskaya, A.; Segal, I.; Kemme, A.; Germane, S.; Popelis, J.; Lukevics, E.; Berger, R.; Spies, H.
Synthese, Struktur, physikochemische und biologische Eigenschaften einiger schwefelhaltiger "3+1" Oxorhenium(V)-Komplexe
Chem. Heterocycl. Compds., 4, 2002, 543-555